These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27607547)

  • 1. Clinical outcomes with a systolic blood pressure lower than 120 mmHg in older patients with high disease burden.
    Franco Palacios CR; Haugen EN; Thompson AM; Rasmussen RW; Goracke N; Goyal P
    Ren Fail; 2016 Oct; 38(9):1364-1369. PubMed ID: 27607547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.
    Navaneethan SD; Roy J; Tao K; Brecklin CS; Chen J; Deo R; Flack JM; Ojo AO; Plappert TJ; Raj DS; Saydain G; Sondheimer JH; Sood R; Steigerwalt SP; Townsend RR; Dweik RA; Rahman M;
    J Am Soc Nephrol; 2016 Mar; 27(3):877-86. PubMed ID: 26386072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients.
    Aggarwal R; Petrie B; Bala W; Chiu N
    Hypertension; 2019 Jun; 73(6):1275-1282. PubMed ID: 31067189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interarm systolic blood pressure as a predictor of cardiovascular events in patients with chronic kidney disease.
    Quiroga B; Galán I; García de Vinuesa S; Goicoechea M; Verdalles Ú; Luño J
    Nephrol Dial Transplant; 2015 May; 30(5):801-6. PubMed ID: 25753805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.
    McMullan CJ; Lambers Heerspink HJ; Parving HH; Dwyer JP; Forman JP; de Zeeuw D
    Am J Kidney Dis; 2014 Nov; 64(5):714-22. PubMed ID: 25064674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting.
    Völler H; Gitt A; Jannowitz C; Karoff M; Karmann B; Pittrow D; Reibis R; Hildemann S
    Eur J Prev Cardiol; 2014 Sep; 21(9):1125-33. PubMed ID: 23508927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of BP with Death, Cardiovascular Events, and Progression to Chronic Dialysis in Patients with Advanced Kidney Disease.
    Palit S; Chonchol M; Cheung AK; Kaufman J; Smits G; Kendrick J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):934-40. PubMed ID: 25979975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Blood Pressure in Late-Stage Chronic Kidney Disease and the Risk of End-Stage Kidney Disease or Mortality (Best Blood Pressure in Chronic Kidney Disease Study).
    Sood MM; Akbari A; Manuel DG; Ruzicka M; Hiremath S; Zimmerman D; McCormick B; Taljaard M
    Hypertension; 2017 Dec; 70(6):1210-1218. PubMed ID: 29061722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of lower achieved blood pressure on outcomes in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
    J Hypertens; 2012 Apr; 30(4):802-10; discussion 810. PubMed ID: 22343536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Target values in hypertension treatment. Will they apply in older patients with hypertension, diabetics and in patients with IHD?].
    Widimský J
    Vnitr Lek; 2009 Sep; 55(9):833-40. PubMed ID: 19785385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
    J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of visit-to-visit variability of systolic blood pressure with cardiovascular disease, chronic kidney disease and mortality in patients with hypertension.
    Wan EYF; Yu EYT; Chin WY; Fong DYT; Choi EPH; Lam CLK
    J Hypertens; 2020 May; 38(5):943-953. PubMed ID: 31904623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative energy balance, CKD, and risk of cardiovascular and all-cause mortality.
    Iff S; Wong G; Webster AC; Flood V; Wang JJ; Mitchell P; Craig JC
    Am J Kidney Dis; 2014 Mar; 63(3):437-45. PubMed ID: 24210588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.
    Whittle J; Lynch AI; Tanner RM; Simpson LM; Davis BR; Rahman M; Whelton PK; Oparil S; Muntner P
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):471-80. PubMed ID: 26912544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies.
    Hung SC; Lai YS; Kuo KL; Tarng DC
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25944876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interankle systolic blood pressure difference and renal outcomes in patients with chronic kidney disease.
    Chen SC; Tsai YC; Huang JC; Lee SC; Chang JM; Hwang SJ; Chen HC
    Nephrology (Carlton); 2016 May; 21(5):379-86. PubMed ID: 26370877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiography to predict adverse cardiac and vascular events in patients with severe chronic kidney disease (stage 4): a prospective study.
    Lesaffre F; Wynckel A; Nazeyrollas P; Rieu P; Metz D
    Arch Cardiovasc Dis; 2013 Apr; 106(4):220-7. PubMed ID: 23706368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.